Net profit of Supriya Lifescience rose 6.20% to Rs 49.68 crore in the quarter ended December 2025 as against Rs 46.78 crore during the previous quarter ended December 2024. Sales rose 11.20% to Rs 206.44 crore in the quarter ended December 2025 as against Rs 185.65 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales206.44185.65 11 OPM %34.9235.52 - PBDT74.2067.54 10 PBT67.3862.58 8 NP49.6846.78 6 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Net profit of Supriya Lifescience rose 9.27% to Rs 50.43 crore in the quarter ended September 2025 as against Rs 46.15 crore during the previous quarter ended September 2024. Sales rose 20.31% to Rs 199.83 crore in the quarter ended September 2025 as against Rs 166.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales199.83166.10 20 OPM %36.3638.96 - PBDT74.9666.81 12 PBT68.3262.07 10 NP50.4346.15 9 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Supriya Lifesciences announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live News